Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 16UNKNOWN 3NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 79Other hematologic neoplasm 59Thoracic 30CNS 26Sarcoma 21Myeloid 12Genitourinary 9Classical hematology 8Plasma cell 6Endocrine 4Other solid neoplasm 3Gynecologic 3Dermatologic 3Breast 3Tumor-Agnostic 1NET 1Head & Neck 1

Conditions

Breast Neoplasms 3

Interventions

Cyclophosphamide 80Paclitaxel 53Trastuzumab 41Tamoxifen 40Doxorubicin 39Specimen Handling 35Docetaxel 35Magnetic Resonance Spectroscopy 34Radiotherapy 33Taxes 30Fluorouracil 26Chemotherapy, Adjuvant 26Carboplatin 24Epirubicin 22Biopsy 22Filgrastim 21Neoadjuvant Therapy 19Methotrexate 19aldesleukin 17Peripheral Blood Stem Cell Transplantation 16Bevacizumab 14Anastrozole 14exemestane 13Lapatinib 13veliparib 12CMF regimen 12sargramostim 11Goserelin 11Fulvestrant 11Capecitabine 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Etoposide × Breast × Clear all
NCT00012311 2014-01-06

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Breast

Breast Neoplasms

NCT00004900 2013-05-30

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Breast

Breast Neoplasms

NCT00004906 2013-05-30

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡